example of an apa literature review essays customer care writing literature review for dissertation research paper about environment i need help editing my essay

Catalogue of Services

What do LS RIs offer the life science community?

 

The 13 European Life Science Research Infrastructures (LS RIs) have the mission to support cutting-edge science by offering access to their resources and services to European scientists from academia and industry.

Resources and services can simply be consultation, access to experts, but also access to data and biological samples, use of data analysis tools, access to facilities (e.g. highly specialised microscopes) plus support from technicians and much more.

Some of these services are even free to use for institutions location in the RI's member states. 

 

The Catalogue of Services, which has been developed within the CORBEL project, is the first tool to list the main services of all LS RIs at a glance and it aims to facilitate the utilisation of RI services by researchers from all over the world. The Catalogue of Services as displayed below aims to provide you a basic overview on existing services within distinct thematic fields.

 

You can either use the Catalogue of Services to identify a single RI to help you with your work or you can create a service pipeline, i.e. using several RIs simultaneously.

What’s your need?

Please select…

EMBRC

Contact person(s): info(at)embrc.eu

The European Marine Biological Research Centre (EMBRC-ERIC) is a Research Infrastructure including 29 Operators across 9 different European countries. EMBRC is dedicated for marine biology and ecology research. EMBRC offers to the scientific community, academic institutions and private companies a comprehensive set of services to study marine organisms and to give access to ecosystems. EMBRC is providing local or remote access to state-of-the-art national facilities such as renowned marine biological stations.

Services provided

The EMBRC service offer includes

  • access to ecosystems: coastal research vessels, scientific diving facilities, submersibles (ROV/AUV), in-situ sampling facilities and monitoring equipment, field stations
  • marine biological resources (micro & macro, alive & fixed, wild & cultivated): biobanks, culture collections (algae, bacteria, zooplankton... within RCC, MOLA, PCC, MCCV), marine model organisms, sampling upon request
  • experimental facilities: aquaria & mesocosms, wet and dry laboratories, climate rooms, field experiment
  • technology platforms: aquaculture, biological analysis, imaging, molecular biology and ‘omics, remote sensing and telemetry, structural and chemical analysis, other
  • e-Infrastructure, data & services: data, data analysis tools and softwares, computing and storage infrastructure, bioinformatics and data management services
  • supporting facilities: in-house lodging, in-house catering (administrative restaurant), workspaces (e.g. offices, conference and meeting rooms with videoconference system), training facilities, lab spaces (wet laboratories, aquariums with different volumes capacities)

Costs

Prices depend on the nature of the service and are available upon request.

Access modes

Through the 29 European operators, users can access the services remotely or on-site. The user has to select the service of interest, submit a proposal and he/she will receive feedback or be contacted.

Why work with us

Researchers should contact us in order to have access to marine ecosystems, marine biological resources and associated technological platforms for analysis.

Countries involved

BE, ES, FR, IT, GR, NO, PT, IL, UK

Services contact

Contact person(s): info(at)embrc.eu

About

The EMBRC-ERIC is a pan-European distributed research infrastructure that aims to provide a strategic delivery mechanism for excellent and large-scale marine biological and ecological research in Europe. With its services, EMBRC will support both fundamental and applied research based on marine bioresources and ecosystems.

In particular, EMBRC aims to drive forward the development of blue biotechnologies. 

Catering for users from academia, industry, policy and the technology sectors, EMBRC provides a unique entry point to access an integrated portfolio of services, bio-technology research platforms and marine organisms, as well as analytical and historical environmental data, to investigate the potential of the marine bioresources to deliver for societally relevant research domains:

  1. Human health and well-being: Marine organisms have historically proven to be fundamental models to understand human cell physiology. More recently, the untapped chemistry of marine natural products is providing the necessary novel bioactives and biomaterials to address the issues of antibiotic resistance, cancer therapy, tissue regeneration and drug delivery, among others. EMBRC is the first step of the health and well-being biodiscovery pipeline based on the sustainable use of marine bioresources.
  2. Sustainability of food production: With a soaring global demand for protein, and aquaculture recently surpassing beef farming production, marine biology and ecology are key disciplines to create sustainable harvesting/rearing programmes and policies. EMBRC provides state of the art facilities to test the impact of treatments, such as nutrition and/or health measures, as well as the effects of environmental conditions, on the productivity of reared biological resources.
  3. Industrial process innovation: Marine enzymes and proteins can support novel process development in the chemical industries; efficient and effective cultivation methods and technologies, as well as extraction techniques are also in high demand by the bio-refinery industry. EMBRC is key to specifically bioprospecting marine biota for white biotechnology applications.
  4. Environmental adaptations to climate and pollution: In depth knowledge of marine biology and ecology is essential to preserve the natural marine environment and its services. EMBRC can provide the indoor and outdoor scalable settings to experiment the impact of different environmental conditions on biota, as well as mitigation and remediation measures.  

Delegated services as well as private research are available at the EMBRC premises, satisfying both academic and industrial users. Excellence of research will be supported creating a virtuous mechanisms and a recognizable quality label, stimulating mutual development and building on reciprocal prestige. Coordinating a wide range of expertise in various research domains, EMBRC will be driven by a truly multidisciplinary community, setting the goals and achieving the objectives of the EU research and innovation agenda.

General contact

Website: www.embrc.eu

Contact person(s): secretariat(at)embrc.eu

ERINHA

Contact person(s): Dr. Hervé Raoul, Diana Stepanyan-Yerdamian, contact(at)erinha.eu

ERINHA is a pan-European distributed life sciences research Infrastructure dedicated to the study of highly infectious emerging and re-emerging high-consequence pathogens (RG4 & unknown). It brings together leading European high containment and complementary research facilities and expertise required to perform cutting-edge research on highly infectious diseases. ERINHA provides access to its state of art BSL-4 laboratories and complementary capacities and expertise to perform excellence orientated in-vitro and in-vivo research projects, trainings and advise. A wide range of capabilities and functions from high basic research laboratory capacities to NHP modeling research are provided by ERINHA, as well as expertise of senior scientists and access to complementary functions (from BSL1 to BSL4, genomics, proteomics etc.).

 

ERINHA produces the ideal environment to facilitate coordination of research on high-consequence pathogens in Europe. The infrastructure will contribute to the enhancement of the European and global capacity, capability and emergency preparedness in the response to global outbreaks.

 

Since 2018, ERINHA has been granted landmark status by the European Strategy Forum on Research Infrastructures (ESFRI).

 

Services provided

The services offered by ERINHA include

  • Access to state of art European high containment (BSL4 & BSL3) and complementary facilities to advance research on high-consequence pathogens. In-vivo testing with a variety of animal models (including small rodents, ferrets, and non-human primates). In-vitro experiments using highly pathogenic agents with both in-person and remote access possibilities.
  • Project coordination and management of large scale research programmes on high consequence pathogens
  • Training (General Biosecurity Training; Operations of a Biosafety Laboratory; Training for potential users)
  • Advice and scientific expertise provider: RG4 pathogens research, containment facilities construction, biosafety/biosecurity issues, sample transport etc.
  • Access to pathogens specimens

Costs

For access costs information contact ERINHA Central Coordinating Unit (CCU) at contact(at)erinha.eu

Access modes

ERINHA provides in-person and remote access to its services. Projects can be submitted by academic, public and industrial users. For more information contact ERINHA CCU at contact(at)erinha.eu

Why work with us

The 2014-2015 Ebola outbreak and cases in Europe demonstrated the worldwide vulnerability and need for common action putting together rare high containment capacities and expertise to be able to increase European and global preparedness for outbreaks of high consequence pathogens. ERINHA facilitates access to required infrastructure capacities thanks to its CCU and multiple high containment and complementary European resources. It is a unique coordinated infrastrucuture providing transnational access to its facilities, large scope of services and shorter delays in access.

Countries involved

France (Inserm), Portugal (INSA), Sweden (FOHM), Hungary (Ministry of Human Capacities), Netherlands (ERASMUS MC), Belgium (KUL)

Services contact

Contact person(s): Dr. Hervé Raoul, Diana Stepanyan-Yerdamian, contact(at)erinha.eu

About

ERINHA is a pan-European distributed life sciences research Infrastructure dedicated to the study of highly infectious emerging and re-emerging high-consequence pathogens (RG4 & unknown). It brings together leading European high containment and complementary research facilities and expertise required to perform cutting-edge research on highly infectious diseases. ERINHA provides access to its state of art BSL-4 laboratories and complementary capacities and expertise to perform excellence orientated in-vitro and in-vivo research projects, trainings and advise. A wide range of capabilities and functions from high basic research laboratory capacities to NHP modeling research are provided by ERINHA, as well as expertise of senior scientists and access to complementary functions (from BSL1 to BSL4, genomics, proteomics etc.). 

ERINHA produces the ideal environment to facilitate coordination of research on high-consequence pathogens in Europe. The infrastructure will contribute to the enhancement of the European and global capacity, capability and emergency preparedness in the response to global outbreaks.

Since 2018, ERINHA has been granted landmark status by the European Strategy Forum on Research Infrastructures (ESFRI).

General contact

Website: www.erinha.eu

Contact person(s): Dr. Hervé Raoul, contact(at)erinha.eu

INFRAFRONTIER

Contact person(s): INFRAFRONTIER Scientific User Support

INFRAFRONTIER is the European research infrastructure for the development, phenotyping, archiving and distribution of model mammalian genomes. It is formed by more than 25 research centres in 14 European countries and Canada. In INFRAFRONTIER these partners join forces to commonly advance the basic understanding of human health and disease using mouse and rodent models.

Services provided

Services offered by INFRAFRONTIER include

  • archiving and distribution of scientifically valuable mutant mouse strains
  • rodent model development (mouse and rat) using gene targeting in embryonic ES-cells or CRISPR/CAS9 technologies
  • systemic phenotyping of mutant mice for a whole-organism view on gene function
  • germ-free (axenic) mice
  • validated genetically engineered mouse models of cancer
  • access to comprehensinve expertise and training

    Costs

    Some of the INFRAFRONTIER resources and services are provided free of charge, others entail user fees to recover costs.
    There are periodic Open Calls to fund researchers, for detailed information see the INFRAFRONTIER website.
    For further information please contact us.

    Access modes

    Access modalities vary with the kind of resource or service requested.
    For further information please contact us.

    Why work with us

    INFRAFRONTIER provides access to unique resources and expertise to advance the understanding of human health and disease using mammalian models. Our users can rely on highest quality standards and long-standing experience. INFRAFRONTIER’s one-stop-shop facilitates efficient research.

    Countries involved

    DE, GR, FI, CZ, FR, EMBL

    Services contact

    Contact person(s): INFRAFRONTIER Scientific User Support

    About

    Europe urgently needs to find solutions for the grand challenges in the area of health. Different forms of cancer, metabolic diseases such as diabetes and obesity, chronic lung diseases, cardiovascular diseases, rare diseases, and infectious diseases are global threats to socio-economic well-being.

    Mammalian models have proven to be a key resource for biomedical research to understand human diseases and to develop treatments for them. Mouse studies have been key to the six of the last 10 Nobel Awards in Medicine and Physiology and to breakthrough discoveries in the functional basis of human health and disease and are used in pre-clinical screening and drug development. The INFRAFRONTIER Research Infrastructure provides access to centralised high-quality resources and data for the development, phenotyping, archiving and distribution of mammalian models. Access is provided for individual researchers (bottom-up access) and for national, European and international research programmes (top-down access).

    The INFRAFRONTIER Mouse Clinics offer access to a comprehensive first-line systemic phenotypic analysis covering a wide range of physiological functions ranging from cardiovascular, neuro-behaviour and metabolism expertise to detailed pathology assessments.

    The nodes of the European Mouse Mutant Archive (EMMA) establish and manage a unified non-profit repository for maintaining medically relevant mouse mutants and making them available to the scientific community. EMMA is by far the largest mouse repository in Europe and the third-largest non-profit mouse archive worldwide. EMMA comprises over 5200 mutant mouse lines carrying targeted, transgenic, induced and other types of mutations.

    INFRAFRONTIER also provides specialised services, training and consulting.

    General contact

    Website: www.infrafrontier.eu

    Contact person(s): info(at)infrafrontier.eu

    MIRRI

    Contact person(s): MIRRI Interim Secretariat

    MIRRI is the pan-European research infrastructure for microbial resources [i.e. bacteria (including cyanobacteria), archaea, fungi, yeasts, plant viruses, bacteriophages and their isolated DNA]. In addition, the MIRRI repertoire also covers human, animal and plant cell cultures.

    By provision of high quality microorganisms, associated data and the broad expertise of our partners, MIRRI aims to support research and development in the field of biotechnology.

    Services provided

    MIRRI services comprise

    • access to microorganisms/cell lines deposited in public collections
    • deposit of microorganisms/cell lines (public collection/patents)
    • phenotypic/molecular characterisation of microorganisms
    • identification/molecular typing of microorganisms
    • isolation/cultivation/preservation of microorganisms
    • microbial community analyses
    • microbial phylogenetic studies
    • screening/bioassays with microorganisms
    • access to microbiological databases
    • consultancy/contract research
    • legal issues (e.g. Nagoya Protocol)
    • biosafety/biosecurity
    • training

    Costs

    Costs depend on the kind of service requested.
    For further information please contact us.

    Access modes

    Access modes depend on the kind of service requested.
    For further information please contact us.

    Why work with us

    MIRRI offers not only a broad spectrum of high quality microorganisms, but also a longlasting expertise in each field of microbiology. Aiming at harmonising the current microbial Biological Resource Centre (mBRC) landscape, MIRRI enables facilitated access to deposited microorganisms and is constantly improving the corresponding state-of-the-art service offers. Our experts ensure legal compliance of resources (Nagoya Protocol) and with the envisaged interoperability of existing and future databases researchers can exploit the full value of microorganisms.

    Countries involved

    under development

    Services contact

    Contact person(s): MIRRI Interim Secretariat

    About

    MIRRI-ERIC provides a unique access point to biological resources, related information, services and expertise of 35 microbial resource centres (mBRCs) located in 10 countries. This means that about 450.000 resources (such as bacteria -including cyanobacteria-, archaea, fungi, yeasts, plant viruses, bacteriophages and their isolated DNA as well as human, animal and plant cell cultures) can be readily provided to users from academia, health and agriculture authorities, and the bio-industry. Pathogenic material is provided to risk group 2, selected risk group 3 organisms are available from a few mBRCs. In addition MIRRI-ERIC offers unrivalled expertise in the integrated analysis of complex microbial interactions, ranging from the isolation of a specimen from the environment to the description of novel species, deciphering the genomic information and its path to gene expression. Targeted identification of genes of interest for biotechnological exploitation as well as analysis of ‘microbiomes’ make MIRRI-ERIC an interesting partner not only for academic researchers but also for industry and ‘personalized medicine’.

    Currently MIRRI-ERIC is under development, but basic services are already available. Full operability as well as the virtual entry point to all services will be achieved once the legal status is established.

    General contact

    Website: www.mirri.org

    Contact person(s): info(at)mirri.org

    Please note: Most of the RIs are constantly developing their portfolio of services, so if you do not find the service/tool you are looking for, do not hesitate to contact the RI and ask for it!

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.